FEZZA, FILOMENA
 Distribuzione geografica
Continente #
NA - Nord America 19.742
EU - Europa 1.247
AS - Asia 563
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
AF - Africa 2
Totale 21.577
Nazione #
US - Stati Uniti d'America 19.735
SG - Singapore 352
UA - Ucraina 256
IE - Irlanda 183
DE - Germania 177
IT - Italia 142
CN - Cina 128
SE - Svezia 98
FR - Francia 86
PL - Polonia 80
GB - Regno Unito 67
FI - Finlandia 58
KR - Corea 55
RU - Federazione Russa 53
BE - Belgio 13
CZ - Repubblica Ceca 11
BR - Brasile 7
EU - Europa 6
HU - Ungheria 6
JP - Giappone 6
KG - Kirghizistan 6
CA - Canada 5
ES - Italia 5
AU - Australia 4
IL - Israele 4
IR - Iran 4
CL - Cile 3
GR - Grecia 3
HK - Hong Kong 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
MY - Malesia 2
NL - Olanda 2
SC - Seychelles 2
DK - Danimarca 1
DM - Dominica 1
ID - Indonesia 1
IN - India 1
LV - Lettonia 1
MD - Moldavia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
Totale 21.577
Città #
Woodbridge 5.872
Wilmington 5.457
Houston 4.718
Fairfield 673
Ann Arbor 481
Chandler 370
Singapore 318
Seattle 271
Ashburn 257
Jacksonville 245
Cambridge 223
Dublin 179
Medford 145
Dearborn 121
Santa Clara 79
Kraków 78
Lawrence 66
Beijing 64
Mülheim 39
New York 39
San Diego 30
Rome 29
Menlo Park 28
Moscow 19
San Mateo 16
Boardman 15
Brussels 13
Milan 13
Brno 11
Los Angeles 11
Verona 11
London 10
Zhengzhou 10
Redwood City 9
Hefei 7
Nanjing 7
Saint Petersburg 7
Chicago 6
Detroit 6
Falls Church 6
Kunming 6
Palo Alto 6
Berlin 5
Cagliari 5
Helsinki 5
Shanghai 5
University Park 5
Auburn Hills 4
Justice 4
Miskolc 4
Mountain View 4
Munich 4
Naples 4
Norwalk 4
Nürnberg 4
Redmond 4
Seoul 4
Siena 4
São Paulo 4
Catania 3
Indiana 3
San Francisco 3
Toronto 3
Ypsilanti 3
Agliana 2
Budapest 2
Dongguan 2
Garden City 2
Guangzhou 2
Hangzhou 2
Hong Kong 2
Hounslow 2
Jinan 2
Lappeenranta 2
Napoli 2
Ningbo 2
Pianella 2
Sant'Angelo del Pesco 2
Suceava 2
Tel Aviv 2
Venafro 2
Wenzhou 2
Adelaide 1
Amsterdam 1
Athens 1
Auckland 1
Augusta 1
Bari 1
Baulkham Hills 1
Caserta 1
Central 1
Changchun 1
Changsha 1
Chaoyang 1
Chatsworth 1
Chisinau 1
Chiswick 1
Chongqing 1
Claix 1
Clearwater 1
Totale 20.113
Nome #
A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase 483
Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity 456
Endocannabinoids in adipocytes during differentiation and their role in glucose uptake 438
The anandamide membrane transporter and the therapeutic implications of its inhibition 436
Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction 435
Molecular Identification of Albumin and Hsp70 as Cytosolic Anandamide-Binding Proteins 434
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor. 433
Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases. 428
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 423
Endocannabinoids, related compounds and their metabolic routes 423
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol 420
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 418
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. 418
Mouse blastocyts release a lipid which activates anandamide hydrolase in intact uterus 413
Evidence for the intracellular accumulation of anandamide in adiposomes 411
Methods to assay anandamide hydrolysis and transport in synaptosomes. 403
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 403
New insights into endocannabinoid degradation and its therapeutic potential 402
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling 399
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors 398
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties. 396
Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two. 395
Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid system. 394
Design and synthesis of biotinylated probes for n-acyl-ethanolamines 393
null 393
Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system. 392
Levels of N-Acylethanolamines in Human Tumors: In Search of Reliable Data 391
Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system 391
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid 390
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting. 390
Endocannabinoid biochemistry: What do we know after 50 years? 389
Endocannabinoids and their involvement in the neurovascular system. 388
Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation 387
Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor. 384
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 383
Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17 beta-estradiol 382
Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes 381
Pitfalls and solutions in assaying anandamide transport in cells. 379
Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol 378
Differential regulation of fatty acid amide hydrolase promoter in human immune cells and neuronal cells by leptin and progesterone 377
Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus 373
Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. 371
Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells: Implications for anandamide-induced apoptosis 370
The endocannabinoid system in neurodegeneration. 370
Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells. 360
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum 351
Design and synthesis of biotinylated probes for n-acyl-ethanolamines 348
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor 341
Rat and human fatty acid amide hydrolases: overt similarities and hidden differences. 337
Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism 334
Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells 320
Regulation of endocannabinoid system by lipid rafts along the neuroimmune axis 194
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 159
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity 132
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? 125
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 113
Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response 113
The endocannabinoid hydrolase FAAH is an allosteric enzyme 107
Assay of NAPE-PLD Activity 104
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity 95
Lipid Discovery by Combinatorial Screening and Untargeted LC-MS/MS 81
Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1 79
Plant-Derived and Endogenous Cannabinoids in Epilepsy 74
Bisphenol a deranges the endocannabinoid system of primary sertoli cells with an impact on inhibin b production 45
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients 34
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 29
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1 20
Chemical Proteomics Reveals Off-Targets of the Anandamide Reuptake Inhibitor WOBE437 17
Endocannabinoids and platelets - Signalling pathways 16
Endocannabinoids and platelets - Differentiation 16
In silico and in vitro analysis of major cannabis-derived compounds as fatty acid amide hydrolase inhibitors 14
Radiometric Assay of NAPE-PLD Activity 11
Totale 21.680
Categoria #
all - tutte 40.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.536


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.825 0 0 383 543 472 585 493 506 534 424 447 438
2020/20213.658 419 480 394 455 420 434 395 346 63 81 129 42
2021/2022665 22 80 37 22 18 44 36 19 52 74 45 216
2022/2023930 108 82 45 123 70 203 61 59 83 4 68 24
2023/2024230 37 11 11 17 18 55 6 9 10 3 13 40
2024/2025601 74 348 179 0 0 0 0 0 0 0 0 0
Totale 21.680